Temozolomide and Radiation Therapy With or Without Cediranib Maleate in Treating Patients With Newly Diagnosed Glioblastoma
Clinical trial NCT01062425 · COMPLETED
Trial details
- NCT number
- NCT01062425
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-02-26
- Primary completion
- 2015-12-06
- Enrollment
- 261
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.